Fig. 1From: Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-upStudy protocol. A total of 1044 patients underwent randomization in a 1:1 ratio to receive lowest dose (1 mg) or highest dose pitavastatin (4 mg) therapy for 3 years. After propensity score matching, 289 patients were enrolled in each groupBack to article page